Target repurposing unravels avermectins and derivatives as novel antibiotics inhibiting energy‐coupling factor transporters (ECFTs)

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: Target repurposing unravels avermectins and derivatives as novel antibiotics inhibiting energy‐coupling factor transporters (ECFTs) ; day:19 ; month:06 ; year:2024 ; extent:11
Archiv der Pharmazie ; (19.06.2024) (gesamt 11)

Creator: Haupenthal, Jörg
Rafehi, Muhammad
Kany, Andreas M.
Lespine, Anne
Stefan, Katja
Hirsch, Anna K. H.
Schmitt, Sven Marcel

DOI: 10.1002/ardp.202400267

URN: urn:nbn:de:101:1-2406201414158.554513259737

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:56 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Other Objects (12)

Target repurposing unravels avermectins and derivatives as novel antibiotics inhibiting energy‐coupling factor transporters (ECFTs)

Membrane‐Active Metallopolymers: Repurposing and Rehabilitating Antibiotics to Gram‐Negative Superbugs

A Macromolecule Reversing Antibiotic Resistance Phenotype and Repurposing Drugs as Potent Antibiotics

Repurposing of antibiotics for clinical management of COVID-19: a narrative review

Glutamate transporter: an unexpected target for some antibiotics

Antibiotics inhibiting bacterial protein synthesis, and novel resistance mechanisms

Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects

Deciphering metabolic heterogeneity in retinoblastoma unravels the role of monocarboxylate transporter 1 in tumor progression

Aufsatzsammlung

Drug repurposing

Quantifying Dynamic Phenotypic Heterogeneity in Resistant Escherichia coli under Translation‐Inhibiting Antibiotics

Drug repurposing in cardiology

Drug Repurposing in Oncology

Target repurposing unravels avermectins and derivatives as novel antibiotics inhibiting energy‐coupling factor transporters (ECFTs)

Membrane‐Active Metallopolymers: Repurposing and Rehabilitating Antibiotics to Gram‐Negative Superbugs

A Macromolecule Reversing Antibiotic Resistance Phenotype and Repurposing Drugs as Potent Antibiotics

Repurposing of antibiotics for clinical management of COVID-19: a narrative review

Glutamate transporter: an unexpected target for some antibiotics

Antibiotics inhibiting bacterial protein synthesis, and novel resistance mechanisms

Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects

Deciphering metabolic heterogeneity in retinoblastoma unravels the role of monocarboxylate transporter 1 in tumor progression

Aufsatzsammlung

Drug repurposing

Quantifying Dynamic Phenotypic Heterogeneity in Resistant Escherichia coli under Translation‐Inhibiting Antibiotics

Drug repurposing in cardiology

Drug Repurposing in Oncology

Target repurposing unravels avermectins and derivatives as novel antibiotics inhibiting energy‐coupling factor transporters (ECFTs)

Membrane‐Active Metallopolymers: Repurposing and Rehabilitating Antibiotics to Gram‐Negative Superbugs

A Macromolecule Reversing Antibiotic Resistance Phenotype and Repurposing Drugs as Potent Antibiotics

Repurposing of antibiotics for clinical management of COVID-19: a narrative review

Glutamate transporter: an unexpected target for some antibiotics

Antibiotics inhibiting bacterial protein synthesis, and novel resistance mechanisms

Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects

Deciphering metabolic heterogeneity in retinoblastoma unravels the role of monocarboxylate transporter 1 in tumor progression

Aufsatzsammlung

Drug repurposing

Quantifying Dynamic Phenotypic Heterogeneity in Resistant Escherichia coli under Translation‐Inhibiting Antibiotics

Drug repurposing in cardiology

Drug Repurposing in Oncology

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Target repurposing unravels avermectins and derivatives as novel antibiotics inhibiting energy‐coupling factor transporters (ECFTs)

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Target repurposing unravels avermectins and derivatives as novel antibiotics inhibiting energy‐coupling factor transporters (ECFTs)

Membrane‐Active Metallopolymers: Repurposing and Rehabilitating Antibiotics to Gram‐Negative Superbugs

A Macromolecule Reversing Antibiotic Resistance Phenotype and Repurposing Drugs as Potent Antibiotics

Repurposing of antibiotics for clinical management of COVID-19: a narrative review

Glutamate transporter: an unexpected target for some antibiotics

Antibiotics inhibiting bacterial protein synthesis, and novel resistance mechanisms

Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects

Deciphering metabolic heterogeneity in retinoblastoma unravels the role of monocarboxylate transporter 1 in tumor progression

Drug repurposing

Quantifying Dynamic Phenotypic Heterogeneity in Resistant Escherichia coli under Translation‐Inhibiting Antibiotics

Drug repurposing in cardiology

Drug Repurposing in Oncology

Target repurposing unravels avermectins and derivatives as novel antibiotics inhibiting energy‐coupling factor transporters (ECFTs)

Membrane‐Active Metallopolymers: Repurposing and Rehabilitating Antibiotics to Gram‐Negative Superbugs

A Macromolecule Reversing Antibiotic Resistance Phenotype and Repurposing Drugs as Potent Antibiotics

Repurposing of antibiotics for clinical management of COVID-19: a narrative review

Glutamate transporter: an unexpected target for some antibiotics

Antibiotics inhibiting bacterial protein synthesis, and novel resistance mechanisms

Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects

Deciphering metabolic heterogeneity in retinoblastoma unravels the role of monocarboxylate transporter 1 in tumor progression

Drug repurposing

Quantifying Dynamic Phenotypic Heterogeneity in Resistant Escherichia coli under Translation‐Inhibiting Antibiotics

Drug repurposing in cardiology

Drug Repurposing in Oncology

Target repurposing unravels avermectins and derivatives as novel antibiotics inhibiting energy‐coupling factor transporters (ECFTs)

Membrane‐Active Metallopolymers: Repurposing and Rehabilitating Antibiotics to Gram‐Negative Superbugs

A Macromolecule Reversing Antibiotic Resistance Phenotype and Repurposing Drugs as Potent Antibiotics

Repurposing of antibiotics for clinical management of COVID-19: a narrative review

Glutamate transporter: an unexpected target for some antibiotics

Antibiotics inhibiting bacterial protein synthesis, and novel resistance mechanisms

Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects

Deciphering metabolic heterogeneity in retinoblastoma unravels the role of monocarboxylate transporter 1 in tumor progression

Drug repurposing

Quantifying Dynamic Phenotypic Heterogeneity in Resistant Escherichia coli under Translation‐Inhibiting Antibiotics

Drug repurposing in cardiology

Drug Repurposing in Oncology

Related objects

Reset password